Skip to main content
. 2011 Aug 10;2011(8):CD003460. doi: 10.1002/14651858.CD003460.pub3

Khalif 2009.

Methods RCT
Participants 118 IBS patients (Rome II)
Interventions Antispasmodic
oral buscopan (20 mg TID)
buscopan suppository (30 mg OD)
oral drotaverine (80 mg TID)
calcium gluconate tablets (1 TID)
calendula suppository (OD)
Outcomes Pain score
Notes